PIM
RCUS icon

Partner Investment Management’s Arcus Biosciences RCUS Stock Holding History

Partner Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,575
Closed -$17K – 108
2018
Q4 		$17K Sell
1,575
-3,586
-69% -$41.9K 0.02% 87
2018
Q3 		$72K Sell
5,161
-96
-2% -$1.22K 0.06% 106
2018
Q2 		$64K Sell
5,257
-441
-8% -$6.92K 0.05% 104
2018
Q1 		$88K Buy
+5,698
New +$94.9K 0.1% 83

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Partner Investment Management's RCUS Position: Q1 2019 in Review

Partner Investment Management sold out of Arcus Biosciences (RCUS) in Q1 2019, closing a stake of 1,575 shares — an estimated $17K sold.

Partner Investment Management first reported a position in RCUS in Q1 2018 and held it in 4 quarters. The position peaked at $88K in Q1 2018. 64 funds tracked by Wall St. Rank hold RCUS as of Q1 2019.

  • Partner Investment Management reported no remaining Arcus Biosciences position as of Q1 2019 after selling out during the quarter.
  • Partner Investment Management sold 1,575 Arcus Biosciences shares in Q1 2019, an estimated $17K.
  • Partner Investment Management first reported a position in Arcus Biosciences in Q1 2018 and held it in 4 quarters.
  • Partner Investment Management's Arcus Biosciences position peaked at $88K in Q1 2018.
  • 64 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2019.

Based on Partner Investment Management's 13F filing for Q1 2019, filed 15 May 2019.